TickerFactsScreenerDevelopers

Cogent Biosciences, Inc. (COGT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$25.84M2018: -$32.49M2019: -$41.51M2020: -$35.85M2021: -$58.76M2022: -$118.64M2023: -$153.62M2024: -$207.79M2025: -$264.44M-$264.44M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$264.44M-27.3%
2024-$207.79M-35.3%
2023-$153.62M-29.5%
2022-$118.64M-101.9%
2021-$58.76M-63.9%
2020-$35.85M+13.6%
2019-$41.51M-27.8%
2018-$32.49M-25.8%
2017-$25.84M—